Table 3.

The comparison of lipid metabolism parameters among three groups of patients with schizophrenia

	Drug-naïve patients n=70	Antipsychotic-treated patients n=33	Antipsychotic discontinuation patients n=28	F	P-value	Pairwise comparison (P-value)
						Drug-naïve vs antipsychotic-treated	Antipsychotic-treated vs discontinuation	Drug-naïve vs antipsychotic discontinuation
TC (mmol/L)	4.16 (0.77)	4.51 (1.07)	4.28 (1.07)	0.226	0.798	0.997	0.588	0.579
TG (mmol/L)	1.12 (0.75)	1.89 (1.08)	1.37 (0.93)	0.147	0.863	0.595	0.687	0.860
HDL-C (mmol/L)	1.29 (0.26)	1.09 (0.24)	1.12 (0.29)	4.338	0.015	0.012	0.766	0.009
LDL-C (mmol/L)	2.50 (0.67)	2.87 (1.04)	2.67 (0.82)	0.189	0.828	0.768	0.791	0.541
aPOA1(g/L)	1.20 (0.22)	1.14 (0.19)	1.14 (0.25)	2.448	0.091	0.050	0.722	0.055
aPOB100 (g/L)	0.63 (0.15)	0.74 (0.22)	1.69 (5.35)	0.076	0.927	0.770	0.703	0.940

Note: Values are means (standard deviation) unless otherwise indicated.

Abbreviations: aPOA1, apolipoprotein A1; aPOB100, apolipoprotein B100; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; WHR, waist–hip ratio.